Nevakar Revenue and Competitors
Estimated Revenue & Valuation
- Nevakar's estimated annual revenue is currently $4.1M per year.
- Nevakar received $30.0M in venture funding in December 2018.
- Nevakar's estimated revenue per employee is $100,500
- Nevakar's total funding is $85M.
Employee Data
- Nevakar has 41 Employees.
- Nevakar grew their employee count by -33% last year.
Nevakar's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Associate VP, Technical Operations | Reveal Email/Phone |
3 | VP, R&D | Reveal Email/Phone |
4 | VP and Head Ophthalmology | Reveal Email/Phone |
5 | VP Human Resources | Reveal Email/Phone |
6 | SVP Program Management | Reveal Email/Phone |
7 | Associate Director Regulatory Affairs | Reveal Email/Phone |
8 | Sr. Director, Quality & Compliance | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Director CMC QA and Quality Systems | Reveal Email/Phone |
Nevakar Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Nevakar?
Repositioning Drugs for a Better Outcome. Nevakar is a specialty injectable pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space. Our goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts.
keywords:Biotechnology,Healthcare,Pharmaceuticals
$85M
Total Funding
41
Number of Employees
$4.1M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nevakar News
Endo International plc (ENDP) - Nevakar Injectables Receives U.S. FDA Approval of Ready-to-use Ephedrine Injection in a Prefilled Syringe.
... Clinical and Non-Clinical Studies, Emerging Therapies, and Treatment Algorithm | Companies- Eyenovia Bio, Sydnexis, Nevakar, and Others.
About Nevakar Inc. Nevakar Inc. is a fully integrated privately held, late-stage biopharmaceutical company with an extensive portfolio of...
Nevakar Inc., a Bridgewater, New Jersey-based specialty pharmaceutical company developing multiple products in the ophthalmic and injectable areas, entered into a $20m senior secured term loan with Oxford Finance LLC. As part of the financing agreement, Nevakar may also access an additional $10 ...
Lentesplus.com raised $5M; MondoBrain raised $13.3M; Nevakar raised $20M; UrbanClap raised $50M Lentesplus.com: Lentesplus.com is a contact lens online retailer company. Lentesplus.com has raised $5 million in Series A funding, including from Palm Drive Capital, IGNIA and InQlab. Read more ROA ...
Other Companies in Bridgewater
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.6M | 41 | 8% | N/A |
#2 | $26.4M | 41 | 37% | $355M |
#3 | $4.9M | 41 | -7% | N/A |
#4 | $7.4M | 44 | -10% | N/A |
#5 | $8.8M | 44 | -14% | N/A |
Nevakar Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2016-08-01 | $55.0M | Undisclosed | Article | |
| 2018-12-04 | $30.0M | Undisclosed | Oxford Finance LLC | Article |